HK1203867A1 - 遞送抗偏頭痛化合物的透皮方法和系統 - Google Patents

遞送抗偏頭痛化合物的透皮方法和系統

Info

Publication number
HK1203867A1
HK1203867A1 HK15104294.8A HK15104294A HK1203867A1 HK 1203867 A1 HK1203867 A1 HK 1203867A1 HK 15104294 A HK15104294 A HK 15104294A HK 1203867 A1 HK1203867 A1 HK 1203867A1
Authority
HK
Hong Kong
Prior art keywords
delivery
systems
transdermal methods
migraine compounds
migraine
Prior art date
Application number
HK15104294.8A
Other languages
English (en)
Inventor
Carter R Anderson
Russell L Morris
Terri B Sebree
Original Assignee
Nupathe Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nupathe Inc filed Critical Nupathe Inc
Publication of HK1203867A1 publication Critical patent/HK1203867A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Electrotherapy Devices (AREA)
HK15104294.8A 2006-04-13 2015-05-06 遞送抗偏頭痛化合物的透皮方法和系統 HK1203867A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79181906P 2006-04-13 2006-04-13
US81413106P 2006-06-16 2006-06-16

Publications (1)

Publication Number Publication Date
HK1203867A1 true HK1203867A1 (zh) 2015-11-06

Family

ID=38610170

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15104294.8A HK1203867A1 (zh) 2006-04-13 2015-05-06 遞送抗偏頭痛化合物的透皮方法和系統

Country Status (13)

Country Link
US (4) US7973058B2 (zh)
EP (1) EP2012871A4 (zh)
JP (3) JP5580042B2 (zh)
CN (2) CN101472644B (zh)
AU (1) AU2007238685B2 (zh)
BR (1) BRPI0709965C1 (zh)
CA (2) CA2650412C (zh)
EA (1) EA023147B1 (zh)
HK (1) HK1203867A1 (zh)
IL (1) IL194553A (zh)
MX (1) MX2008012922A (zh)
NZ (2) NZ596498A (zh)
WO (1) WO2007120747A2 (zh)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2650412C (en) * 2006-04-13 2016-09-27 Nupathe, Inc. Transdermal methods and systems for the delivery of anti-migraine compounds
ES2563061T3 (es) * 2008-04-28 2016-03-10 Zogenix, Inc. Nuevas formulaciones para el tratamiento de la migraña
US8366600B2 (en) * 2008-06-19 2013-02-05 Nupathe Inc. Polyamine enhanced formulations for triptan compound iontophoresis
US8155737B2 (en) 2008-06-19 2012-04-10 Nupathe, Inc. Pharmacokinetics of iontophoretic sumatriptan administration
KR101656537B1 (ko) * 2008-06-19 2016-09-09 에르테에스 로만 테라피-시스테메 아게 양이온성 활성제의 경피 전달용 조성물
CN102159205A (zh) 2008-06-25 2011-08-17 Fe3医学有限公司 用于经皮递送治疗有效量的铁的贴片和方法
NZ622157A (en) * 2008-12-30 2015-10-30 Teva Pharmaceuticals Int Gmbh Electronic control of drug delivery system
US8190252B2 (en) 2009-02-12 2012-05-29 Incube Labs, Llc Iontophoretic system for transdermal delivery of active agents for therapeutic and medicinal purposes
US8961492B2 (en) 2009-02-12 2015-02-24 Incube Labs, Llc System and method for controlling the iontophoretic delivery of therapeutic agents based on user inhalation
WO2010093472A2 (en) * 2009-02-12 2010-08-19 Incube Labs, Llc Method and apparatus for oscillatory iontophoretic transdermal delivery of a therapeutic agent
US9095503B2 (en) 2009-02-12 2015-08-04 Incube Labs, Llc System and method for biphasic transdermal iontophreotic delivery of therapeutic agents
US8821945B2 (en) 2009-04-25 2014-09-02 Fe3 Medical, Inc. Method for transdermal iontophoretic delivery of chelated agents
WO2010151845A2 (en) * 2009-06-26 2010-12-29 Incube Labs, Llc Corrosion resistant electrodes for iontophoretic transdermal delivery devices and methods of use
US8845612B2 (en) * 2009-08-10 2014-09-30 Nupathe Inc. Methods for iontophoretically treating nausea and migraine
WO2011044175A2 (en) * 2009-10-06 2011-04-14 Incube Labs, Llc Patch and patch assembly for iontophoretic transdermal delivery of active agents for therapeutic and medicinal purposes
US20110087153A1 (en) * 2009-10-13 2011-04-14 Angelov Angel S Transdermal Methods And Systems For The Delivery Of Rizatriptan
US8685038B2 (en) 2009-12-07 2014-04-01 Incube Labs, Llc Iontophoretic apparatus and method for marking of the skin
US8986279B2 (en) 2010-02-10 2015-03-24 Incube Labs, Llc Methods and architecture for power optimization of iontophoretic transdermal drug delivery
NZ604745A (en) 2010-08-27 2015-01-30 Gruenenthal Chemie Substituted 2-oxy-quinoline-3-carboxamides as kcnq2/3 modulators
EP2609086B1 (en) 2010-08-27 2015-02-25 Grünenthal GmbH Substituted 2-oxo- and 2-thioxo-dihydroquinoline-3-carboxamides as kcnq2/3 modulators
WO2012154704A2 (en) 2011-05-06 2012-11-15 Incube Labs, Llc System and method for biphasic transdermal iontophoretic delivery of therapeutic agents for the control of addictive cravings
US9744353B2 (en) 2012-11-14 2017-08-29 Teva Pharmaceuticals International Gmbh Detection of presence and alignment of a therapeutic agent in an iontophoretic drug delivery device
US9918932B2 (en) 2016-02-19 2018-03-20 Zosano Pharma Corporation Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines
GB2554455A (en) 2016-09-29 2018-04-04 Feeligreen Sa Skin treatment device and method for delivery of an active ingredient into the human skin by means of iontophoresis, using an array of electrodes
US11660264B2 (en) 2017-08-23 2023-05-30 Emergex USA Corporation Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches
CN111278503B (zh) * 2017-09-12 2023-12-05 Lts勒曼治疗系统股份公司 离子电渗微针装置
US11318292B2 (en) * 2018-05-28 2022-05-03 Microneedles Inc. Microneedle patch for transdermal injections
US11660265B2 (en) 2018-06-28 2023-05-30 Emergex USA Corporation Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches
CA3145203A1 (en) 2019-06-28 2020-12-30 Passport Technologies, Inc. Triptan microporation delivery system
US11364225B2 (en) 2019-08-21 2022-06-21 Bn Intellectual Properties, Inc. Pharmaceutical formulation for treating symptoms of migraine and cluster headaches, and method of using the same

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4856188A (en) 1984-10-12 1989-08-15 Drug Delivery Systems Inc. Method for making disposable and/or replenishable transdermal drug applicators
US4557723A (en) * 1983-08-18 1985-12-10 Drug Delivery Systems Inc. Applicator for the non-invasive transcutaneous delivery of medicament
US4883457A (en) * 1983-08-18 1989-11-28 Drug Delivery Systems Inc. Disposable and/or replenishable transdermal drug applicators and methods of manufacturing same
US5651768A (en) 1983-08-18 1997-07-29 Drug Delivery Systems, Inc. Transdermal drug applicator and electrodes therefor
US5605536A (en) 1983-08-18 1997-02-25 Drug Delivery Systems Inc. Transdermal drug applicator and electrodes therefor
US5042975A (en) * 1986-07-25 1991-08-27 Rutgers, The State University Of New Jersey Iontotherapeutic device and process and iontotherapeutic unit dose
US4822802A (en) 1987-02-24 1989-04-18 Alza Corporation Method of fentanly administration for postoperative pain relief
US4865582A (en) * 1987-06-05 1989-09-12 Drug Delivery Systems Inc. Disposable transdermal drug applicators
US5162042A (en) * 1988-07-05 1992-11-10 Alza Corporation Electrotransport transdermal system
US4927408A (en) 1988-10-03 1990-05-22 Alza Corporation Electrotransport transdermal system
US5207752A (en) 1990-03-30 1993-05-04 Alza Corporation Iontophoretic drug delivery system with two-stage delivery profile
DE4014913C2 (de) 1990-05-10 1996-05-15 Lohmann Therapie Syst Lts Miniaturisiertes transdermales therapeutisches System für die Iontophorese
CA2183875C (en) * 1992-06-02 2003-10-14 Robert M. Myers Electrotransport drug delivery device
US5807571A (en) * 1993-05-06 1998-09-15 Lts Lohmann Therapie-Systeme Gmbh Transdermal therapeutic systems for administering indole serotonin agonists
DE4314976C1 (de) 1993-05-06 1994-10-06 Lohmann Therapie Syst Lts Transdermale therapeutische Systeme zur Verabreichung von Wirkstoffen, Verfahren zu ihrer Herstellung und ihre Verwendung
US5458569A (en) 1993-06-08 1995-10-17 Becton Dickinson And Company Wearable iontophoresis system
PH31437A (en) * 1993-08-27 1998-11-03 Janssen Pharmaceutica Nv Tontophoretic delivery of an antimigrane drug.
US5533971A (en) 1993-09-03 1996-07-09 Alza Corporation Reduction of skin irritation during electrotransport
US5697896A (en) 1994-12-08 1997-12-16 Alza Corporation Electrotransport delivery device
JPH08317997A (ja) * 1995-03-17 1996-12-03 Takeda Chem Ind Ltd 経皮透過方法
US5700481A (en) * 1995-03-17 1997-12-23 Takeda Chemical Industries, Ltd. Transdermal drug delivery process
IE960312A1 (en) 1995-06-02 1996-12-11 Alza Corp An electrotransport delivery device with voltage boosting¹circuit
US6216033B1 (en) 1996-05-22 2001-04-10 Alza Corporation Device for transdermal electrotransport delivery of fentanyl and sufentanil
US6425892B2 (en) 1995-06-05 2002-07-30 Alza Corporation Device for transdermal electrotransport delivery of fentanyl and sufentanil
KR100453140B1 (ko) 1995-06-05 2005-02-28 앨자 코포레이션 펜타닐 및 수펜타닐의 경피 전기수송 전달을 위한 장치
US5983130A (en) * 1995-06-07 1999-11-09 Alza Corporation Electrotransport agent delivery method and apparatus
US6245347B1 (en) 1995-07-28 2001-06-12 Zars, Inc. Methods and apparatus for improved administration of pharmaceutically active compounds
US5688232A (en) 1995-09-28 1997-11-18 Becton Dickinson And Company Iontophoretic drug delivery device having an improved controller
US5941843A (en) * 1996-07-12 1999-08-24 Empi, Inc. Iontophoresis electrode
US5968547A (en) * 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
US5882677A (en) * 1997-09-30 1999-03-16 Becton Dickinson And Company Iontophoretic patch with hydrogel reservoir
JP4290271B2 (ja) 1998-04-14 2009-07-01 久光製薬株式会社 経皮透過方法
SE9802864D0 (sv) * 1998-08-27 1998-08-27 Pharmacia & Upjohn Ab Transdermally administered tolterodine as antimuscarinic agent for the treatment of overactive bladder
KR20010112420A (ko) * 1999-04-12 2001-12-20 나까도미 히로다카 이온토포레시스용 디바이스
US6312716B1 (en) * 1999-05-10 2001-11-06 Peierce Management Llc Patch and method for transdermal delivery of bupropion base
US6385488B1 (en) * 1999-05-20 2002-05-07 Vyteris, Inc. Circuits for increasing the reliability of an iontophoretic system
US6421561B1 (en) * 1999-12-30 2002-07-16 Birch Point Medical, Inc. Rate adjustable drug delivery system
DK1642578T3 (da) * 2000-07-31 2013-08-12 Takeda Pharma As Fentanyl salt-sammensætning til nasal administration
US6653014B2 (en) 2001-05-30 2003-11-25 Birch Point Medical, Inc. Power sources for iontophoretic drug delivery systems
DK1435945T3 (da) * 2001-06-05 2008-12-01 Ronald Aung-Din Topisk migræne terapi
WO2003035167A2 (en) * 2001-10-24 2003-05-01 Power Paper Ltd Device and method for controlled delivery of active substance into the skin
RU2004126093A (ru) * 2002-02-26 2005-04-10 Орто-Макнейл Фармасьютикал, Инк. (Us) Комбинированная терапия для лечения мигрени, включающая применение производных противосудорожных средств и средств от мигрени
JP4191951B2 (ja) 2002-04-25 2008-12-03 ソントル ファルマペプティド 抗微生物剤投与装置および組立品
US6975902B2 (en) 2002-06-28 2005-12-13 Alza Corporation Reservoir and a series of related reservoirs for use in an electrotransport drug delivery device and devices comprised thereof
US6745071B1 (en) 2003-02-21 2004-06-01 Birch Point Medical, Inc. Iontophoretic drug delivery system
US20040242770A1 (en) 2003-04-16 2004-12-02 Feldstein Mikhail M. Covalent and non-covalent crosslinking of hydrophilic polymers and adhesive compositions prepared therewith
US8734421B2 (en) * 2003-06-30 2014-05-27 Johnson & Johnson Consumer Companies, Inc. Methods of treating pores on the skin with electricity
US20050228336A1 (en) * 2004-04-07 2005-10-13 Preston Keusch Electrically assisted lidocaine and epinephrine delivery device having extended shelf-stability
UY28935A1 (es) 2004-06-03 2005-07-29 Alza Corp Sistema y metodo para la administracion transdermica de un anticoagulante
WO2006015299A2 (en) * 2004-07-30 2006-02-09 Microchips, Inc. Multi-reservoir device for transdermal drug delivery and sensing
US7856263B2 (en) 2005-04-22 2010-12-21 Travanti Pharma Inc. Transdermal systems for the delivery of therapeutic agents including granisetron using iontophoresis
US20070093788A1 (en) 2005-09-30 2007-04-26 Darrick Carter Iontophoresis method and apparatus for systemic delivery of active agents
CA2650412C (en) * 2006-04-13 2016-09-27 Nupathe, Inc. Transdermal methods and systems for the delivery of anti-migraine compounds

Also Published As

Publication number Publication date
CA2650412A1 (en) 2007-10-25
US9272137B2 (en) 2016-03-01
CN101472644A (zh) 2009-07-01
US7973058B2 (en) 2011-07-05
US20080287497A1 (en) 2008-11-20
BRPI0709965A2 (pt) 2011-08-02
US20110213294A1 (en) 2011-09-01
NZ596498A (en) 2013-05-31
IL194553A (en) 2016-03-31
EA023147B1 (ru) 2016-04-29
CN104138634A (zh) 2014-11-12
JP2014221798A (ja) 2014-11-27
US20110213330A1 (en) 2011-09-01
WO2007120747A3 (en) 2008-04-24
AU2007238685A1 (en) 2007-10-25
EP2012871A4 (en) 2015-07-22
MX2008012922A (es) 2008-12-17
EA200802146A1 (ru) 2009-06-30
CN104138634B (zh) 2016-09-07
BRPI0709965C2 (pt) 2011-12-20
CN101472644B (zh) 2014-04-23
CA2935569A1 (en) 2007-10-25
WO2007120747A2 (en) 2007-10-25
JP5925844B2 (ja) 2016-05-25
EP2012871A2 (en) 2009-01-14
US8470853B2 (en) 2013-06-25
BRPI0709965C1 (pt) 2011-12-20
AU2007238685B2 (en) 2012-09-13
CA2650412C (en) 2016-09-27
JP5580042B2 (ja) 2014-08-27
JP2009533451A (ja) 2009-09-17
JP2016163723A (ja) 2016-09-08
NZ610790A (en) 2015-05-29
US20160317464A1 (en) 2016-11-03

Similar Documents

Publication Publication Date Title
HK1203867A1 (zh) 遞送抗偏頭痛化合物的透皮方法和系統
HK1221477A1 (zh) 多肽及相關化合物的透皮給藥系統
IL206184A0 (en) Systems and methods for delivery of materials
HK1224200A1 (zh) 用於治療胰腺癌的藥物
IL200077A0 (en) Transdermal delivery systems
EP2155039A4 (en) MARKER SYSTEMS AND METHOD FOR THEIR USE
HK1140672A1 (en) Systems and methods for nasal irrigation
IL201650A0 (en) Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
EP2175922A4 (en) DISTRIBUTION SYSTEMS FOR DISTRIBUTING FUNCTIONAL CONNECTIONS TO SUBSTRATES AND METHOD FOR THEIR USE
EP2074150A4 (en) DISCHARGE SYSTEMS AND METHOD FOR THEIR USE
EP2236150A4 (en) METHOD FOR INCREASING THE THERAPEUTIC EFFECTIVENESS OF CURCUMINOIDS AND THE LIKE
EG24893A (en) Apparatus for the connection of strips
EP2147070A4 (en) SYSTEM AND METHOD FOR SURFACE COATING
EP2309938A4 (en) CRYOSURGICAL SYSTEMS AND METHOD OF USE THEREOF
ZA200901525B (en) Discharge systems and methods of using the same
ZA200903401B (en) The uses of the carboxy-amido-triazole compounds and salts thereof
EP2224994A4 (en) SYSTEMS AND METHODS FOR MAGNETICALLY ASSISTED ADMINISTRATION OF A THERAPEUTIC AGENT
IL203064B (en) Pharmaceutical composition comprising 11-deoxy-prostaglandin compound and method for stabilizing the compound
ZA200809004B (en) Autodestructive transdermal therapeutic system
IL243809A0 (en) Process for the production of γ-ketosulfide compound and γ-ketosulfide compounds
HK1130555A1 (en) Methods and systems for determining efficacy of medicaments
PL2896614T3 (pl) Sposoby i związki do wytwarzania normorfinanów
SI2724722T1 (sl) Postopek za obnovitev učinka inkretina
EP2204271A4 (en) PROCESS FOR INJECTING POLYVINYL ALCOHOL (PVA) PARTS AND PARTS SO OBTAINED
GB0602857D0 (en) The treatment of sialorrhoea